Suchergebnisse - (Subject:"lopinavir")

PubPharm (3.163)

41

An economically advantageous amorphous solid dispersion of the fixed combination of lopinavir and ritonavir

enthalten in: Journal of pharmaceutical investigation | 2023

von Yun, T. | Jung, M. | Bang, K. | +8

42

An economically advantageous amorphous solid dispersion of the fixed combination of lopinavir and ritonavir

enthalten in: Journal of pharmaceutical investigation | 2023

von Yun, T. | Jung, M. | Bang, K. | +8

43

A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used in the Pandemic in Iraq on the Clinical Outcome in Patients with SARS-CoV-2

enthalten in: Archives of Razi Institute | 2023

von Alabdalaali, M. | Hadi, A.

44

Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks: a prospective, open-label, randomized controlled trial : Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks : a prospect

enthalten in: WHO International Clinical Trials Registry Platform | 2023

45

Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks: a prospective, open-label, randomized controlled trial : Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks : a prospect

enthalten in: WHO International Clinical Trials Registry Platform | 2023

46

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis

enthalten in: AIDS research and human retroviruses | 2023

von Leal, L. | Guardo, A. | Bedoya, L. | +10

47

Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients : experience from the initial use of lopinavir-ritonavir

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gonzalez-García, R. | Roma, J. | Rodríguez-García, M. | +17

48

Comprehensive micropollutant characterization of wastewater during Covid-19 crisis in 2020 : Suspect screening and environmental risk prioritization strategy

enthalten in: The Science of the total environment | 2023

von Lopez-Herguedas, N. | Irazola, M. | Alvarez-Mora, I. | +5

49

Systemic Review and Meta-Analysis to Evaluate Therapeutic Effectiveness of Interferon Beta-1b in Hospitalized COVID-19 Patients

enthalten in: Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine | 2023

von Nayudu, G. | Benny, M. | Thomas, G. | +2

50

Beneficial effects of Naringin against lopinavir/ ritonavir-induced hyperlipidemia and reproductive toxicity in male albino rats

enthalten in: European review for medical and pharmacological sciences | 2023

von Krishnaraju, V. | Alghazwani, Y. | Durgaramani, S. | +9